Filing Details
- Accession Number:
- 0001214659-19-005387
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-20 16:30:12
- Reporting Period:
- 2019-08-09
- Accepted Time:
- 2019-08-20 16:30:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1398733 | Aquestive Therapeutics Inc. | AQST | Pharmaceutical Preparations (2834) | 208623253 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1406834 | J Keith Kendall | C/O Aquestive Therapeutics, Inc. 30 Technology Drive Warren NJ 07059 | Ceo And President | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-08-09 | 2,000 | $3.84 | 648,581 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-09 | 1,000 | $3.93 | 649,581 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-09 | 2,000 | $4.00 | 651,581 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-13 | 1,000 | $4.05 | 652,581 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-14 | 1,000 | $3.70 | 653,581 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-08-14 | 1,000 | $3.65 | 654,581 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |